期刊
CYTOKINE & GROWTH FACTOR REVIEWS
卷 24, 期 3, 页码 285-295出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2013.03.003
关键词
Activin; Follistatin; Inflammation; Fibrosis; Immunoregulation
资金
- National Health and Medical Research Council
- Victorian Government
The activins, as members of the transforming growth factor-beta superfamily, are pleiotrophic regulators of cell development and function, including cells of the myeloid and lymphoid lineages. Clinical and animal studies have shown that activin levels increase in both acute and chronic inflammation, and are frequently indicators of disease severity. Moreover, inhibition of activin action can reduce inflammation, damage, fibrosis and morbidity/mortality in various disease models. Consequently, activin A and, more recently, activin B are emerging as important diagnostic tools and therapeutic targets in inflammatory and fibrotic diseases. Activin antagonists such as follistatin, an endogenous activin-binding protein, offer considerable promise as therapies in conditions as diverse as sepsis, liver fibrosis, acute lung injury, asthma, wound healing and ischaemia-reperfusion injury. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据